ABSTRACT
During the 23 consecutive annual epidemics of Argentine haemorrhagic fever observed from 1959 to 1983, a group of 4,433 patients were treated at Junin (Argentina) with convalescent's plasma; the overall mortality rate was 3.29%. In 1958, before convalescent's plasma was used, the mortality rate in 448 patients who received the conventional treatment was 42.85%. The difference between the two groups is highly significant and demonstrates the value of convalescent's plasma in the treatment of the disease.
Subject(s)
Hemorrhagic Fever, American/therapy , Immunotherapy/methods , Plasma , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Hemorrhagic Fever, American/diagnosis , Hemorrhagic Fever, American/mortality , Humans , Infant , Male , Middle AgedABSTRACT
A clinical and serological study was performed on 267 of 636 volunteers vaccinated against Argentine hemorrhagic fever with the XJCl3 attenuated strain of Junin virus seven to nine years earlier, in order to determine their long-term evolution. This study included a clinical examination, a chest roentgenogram, an electrocardiogram, and the following laboratory determinations: white and red cell count, number of platelets, hematocrit, hemoglobin, sedimentation rate (Katz index), urea, nitrogen, glucose concentration, cholesterol, GOT, GPT, gamma GT, alkaline phosphatase, cholinesterase, and total bilirubin. Neutralization reactions were performed to determine presistence of antibody levels. All clinical and laboratory findings were within normal limits, excluding a long-term pathology attributable to the virus. Of 165 tested sera, 153 (90.3%) had detectable levels of neutralizing antibodies, and the rest had no antibodies after this time. Although these people live in the endemic area, it is considered that only the 9% that had increased antibody levels had suffered a reinfection during the seven- to nine-year period, which acted as a booster. This figure aproximately coresponds to the subclinical infection value found in the region. In the rest, the persistence of antibodies is attributed to the immunization achieved with the vaccine employed.
Subject(s)
Arenaviridae/immunology , Arenaviruses, New World/immunology , Hemorrhagic Fever, American/immunology , Viral Vaccines/immunology , Adult , Aged , Antibodies, Viral/analysis , Follow-Up Studies , Humans , Middle Aged , Vaccines, Attenuated/immunologyABSTRACT
A procedure that allows to ascertain a diagnosis of Argentine Hemorrhagic Fever (AHF) as early as 24-48 hours after onset of symptoms is described. An immunofluorescent (IF) test on round cells of urinary sediment was employed. The procedure was assayed on 31 patients with febrile syndrome during epidemic peaks of 1975-1976. It was positive in 19 and negative in 12 cases. The 19 positive cases were confirmed AHF by clinical follow up and serology. From 12 negative cases, 8 belonged to other etiologies and 2 were confirmed AHF. The usefulness of the procedure for early diagnosis is emphasized.
